| Zonisamide Viatris 50 mg hard capsules EU/1/16/1093/005-008 |
Zonisamide |
Viatris Limited |
— |
| Zoonotic Influenza Vaccine Seqirus suspension for injection in pre-filled syringe EU/1/23/1761/001-002 |
A/TURKEY/TURKEY/1/05 (H5N1)-LIKE STRAIN (NIBRG-23) |
Seqirus S.r.l. |
— |
| Zopiclone Grindeks 3.75 mg film-coated tablets PA22992/030/001 |
Zopiclone |
AS Grindeks |
Not marketed |
| Zopiclone Grindeks 5 mg film-coated tablets PA22992/030/002 |
Zopiclone |
AS Grindeks |
Not marketed |
| Zopiclone Grindeks 7.5 mg film-coated tablets PA22992/030/003 |
Zopiclone |
AS Grindeks |
Not marketed |
| Zopiclone Pinewood 3.75 mg film-coated tablets PA0281/257/002 |
Zopiclone |
Pinewood Laboratories Ltd |
Not marketed |
| Zopiclone Pinewood 7.5 mg film-coated tablets PA0281/257/001 |
Zopiclone |
Pinewood Laboratories Ltd |
Marketed |
| Zopitan 3.75 mg film-coated tablets PA0126/104/001 |
Zopiclone |
Clonmel Healthcare Ltd |
Marketed |
| Zopitan 7.5 mg film-coated tablets PA0126/104/002 |
Zopiclone |
Clonmel Healthcare Ltd |
Marketed |
| Zorclone 7.5 mg film-coated tablets PA1986/080/001 |
Zopiclone |
Teva B.V. |
Marketed |
| Zoreeda 25 microgram/125 microgram per actuation pressurised inhalation, suspension PA1963/009/001 |
Fluticasone propionate, Salmeterol |
Cipla Europe NV |
Not marketed |
| Zoreeda 25 microgram/250 microgram per actuation pressurised inhalation, suspension PA1963/009/002 |
Fluticasone propionate, Salmeterol |
Cipla Europe NV |
Not marketed |
| Zoton FasTab 15 mg Oro-Dispersible Tablets PA0822/101/002 |
Lansoprazole |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Zoton FasTab 30 mg oro-dispersible tablets PA0822/101/003 |
Lansoprazole |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Zovirax 200 mg Dispersible Tablets PA1077/084/007 |
Aciclovir |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Zovirax 200 mg Dispersible Tablets PPA1463/199/001 |
Aciclovir |
IMED Healthcare Ltd., |
— |
| Zovirax 200 mg/5 mL oral suspension PPA0465/038/008 |
Aciclovir |
PCO Manufacturing Ltd. |
— |
| Zovirax 200 mg/5 mL Oral Suspension PA1077/084/005 |
Aciclovir |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Zovirax 200 mg/5 mL Oral Suspension PPA1463/199/003 |
Aciclovir |
IMED Healthcare Ltd., |
— |
| Zovirax 5% w/w Cream PA1077/084/001 |
Acyclovir |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Zovirax 5% w/w Cream PPA1463/199/004 |
Acyclovir |
IMED Healthcare Ltd., |
— |
| Zovirax 800 mg Dispersible Tablets PPA23080/029/001 |
Aciclovir |
Merit Pharmaceuticals Limited |
— |
| Zovirax 800 mg Dispersible Tablets PPA2306/030/001 |
Aciclovir |
Originalis B.V. |
— |
| Zovirax Cold Sore 5% w/w Cream PA0678/090/002 |
Aciclovir |
Haleon Ireland Limited |
Marketed |
| Zovirax Double Strength 400 mg/5 mL Oral Suspension PA1077/084/006 |
Acyclovir |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Zovirax Duo 50 mg/g and 10 mg/g Cream PA0678/143/001 |
ACICLOVIR PH. EUR., HYDROCORTISONE PH. EUR. |
Haleon Ireland Limited |
Not marketed |
| Zovirax IV for Infusion 250 mg, Powder for solution for infusion PA1077/084/003 |
Aciclovir |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| ZTALMY 50 mg/mL oral suspension EU/1/23/1743/001-002 |
Ganaxolone |
Marinus Pharmaceuticals Emerald Limited |
— |
| Zubsolv 0.7 mg/0.18 mg Sublingual tablet EU/1/17/1233/001 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate |
Accord Healthcare S.L.U. |
— |
| Zubsolv 1.4 mg/0.36 mg sublingual tablets EU/1/17/1233/002 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate |
Accord Healthcare S.L.U. |
— |
| Zubsolv 11.4 mg/2.9 mg Sublingual tablet EU/1/17/1233/006 |
Naloxone hydrochloride dihydrate, Buprenorphine hydrochloride |
Accord Healthcare S.L.U. |
— |
| Zubsolv 2.9 mg/0.71 mg Sublingual tablet EU/1/17/1233/003 |
Naloxone hydrochloride dihydrate, Buprenorphine hydrochloride |
Accord Healthcare S.L.U. |
— |
| Zubsolv 5.7 mg/1.4 mg Sublingual tablet EU/1/17/1233/004 |
Naloxone hydrochloride dihydrate, Buprenorphine hydrochloride |
Accord Healthcare S.L.U. |
— |
| Zubsolv 8.6 mg/2.1 mg Sublingual tablet EU/1/17/1233/005 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate |
Accord Healthcare S.L.U. |
— |
| Zurzuvae 20 mg hard capsules EU/1/25/1977/001-003 |
Zuranolone |
Biogen Netherlands B.V. |
— |
| Zurzuvae 25 mg hard capsules EU/1/25/1977/004-006 |
Zuranolone |
Biogen Netherlands B.V. |
— |
| Zurzuvae 30 mg hard capsules EU/1/25/1977/007 |
Zuranolone |
Biogen Netherlands B.V. |
— |
| Zutectra 500 IU solution for injection in pre-filled syringe EU/1/09/600/001 |
Human plasma protein >96% immunoglobulins, Hbs antibodies |
Biotest Pharma GmbH |
— |
| Zvogra 120 mg solution for injection EU/1/25/1981/001-003 |
Denosumab |
Stada Arzneimittel AG |
— |
| Zyban 150 mg prolonged release tablets PA1077/017/001 |
Bupropion hydrochloride |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Zyban 150 mg prolonged release tablets PPA2306/005/001 |
Bupropion hydrochloride |
Originalis B.V. |
— |
| Zyban 150 mg prolonged release tablets PPA0465/496/001 |
Bupropion hydrochloride |
PCO Manufacturing Ltd. |
— |
| Zyban 150 mg prolonged release tablets PPA23080/035/001 |
Bupropion hydrochloride |
Merit Pharmaceuticals Limited |
— |
| Zyban 150 mg prolonged-release tablets PPA1463/229/001 |
Bupropion hydrochloride |
IMED Healthcare Ltd., |
— |
| Zyclara 3.75% cream EU/1/12/783/001-003 |
Imiquimod |
Viatris Healthcare Limited |
— |
| Zydelig 100 mg film-coated tablets EU/1/14/938/001 |
Idelalisib |
Gilead Sciences Ireland UC |
— |
| Zydelig 150 mg film-coated tablets EU/1/14/938/002 |
Idelalisib |
Gilead Sciences Ireland UC |
— |
| ZYDOL 50 mg Hard Capsules PA2242/005/001 |
Tramadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| ZYDOL SR 100 mg prolonged-release tablets PA2242/005/003 |
Tramadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |
| ZYDOL SR 150 mg prolonged-release tablets PA2242/005/004 |
Tramadol hydrochloride |
Grunenthal Pharma Limited. |
Marketed |